Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulopathy”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07642050
What this trial is testing

Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Biohaven Therapeutics Ltd. 420
Not applicableUnknownNCT05797051
What this trial is testing

Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases

Who this might be right for
Glomerulonephritis, IGAGlomerulonephritis, MembranousDiabetic Nephropathies+2 more
Qianfoshan Hospital 80
Not applicableLooking for participantsNCT03929887
What this trial is testing

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Who this might be right for
Glomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more
Seoul National University Hospital 3,000
Not applicableStudy completedNCT05428605
What this trial is testing

In Vitro Immunomodulation in Membranous Nephropathy Relapses

Who this might be right for
Extramembranous Glomerulopathy
Centre Hospitalier Universitaire de Nice 20
Testing effectiveness (Phase 2)Looking for participantsNCT04183101
What this trial is testing

Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

Who this might be right for
C3 GlomerulopathyMembranoproliferative GlomerulonephritisComplement Abnormality+2 more
Region Skane 30
Not applicableStudy completedNCT00255398
What this trial is testing

Kidney Disease Biomarkers

Who this might be right for
Kidney DiseaseGlomerular DiseaseIdiopathic Nephrotic Syndrome+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Not applicableStudy completedNCT04380610
What this trial is testing

Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

Who this might be right for
Sickle Cell DiseaseRenal DiseaseGlomerular Disease
University of Alabama at Birmingham 120
Not applicableStudy completedNCT02147210
What this trial is testing

Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1

Who this might be right for
Kidney Transplantation
University Hospital, Toulouse 60
Post-approval studies (Phase 4)UnknownNCT05546047
What this trial is testing

Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

Who this might be right for
Fibrillary Glomerulonephritis
NephroNet, Inc. 34
Not applicableStudy completedNCT00001393
What this trial is testing

Genetic Markers for Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisHIV-Associated Focal Segmental Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 616
Large-scale testing (Phase 3)Study completedNCT05067127
What this trial is testing

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Who this might be right for
C3GIC-MPGNC3 Glomerulopathy+9 more
Apellis Pharmaceuticals, Inc. 124
Testing effectiveness (Phase 2)Ended earlyNCT03459443
What this trial is testing

A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471

Who this might be right for
C3 GlomerulonephritisC3 GlomerulopathyImmune Complex Membranoproliferative Glomerulonephritis+2 more
Alexion Pharmaceuticals, Inc. 22
Not applicableStudy completedNCT00001392
What this trial is testing

Pathogenesis of Glomerulosclerosis

Who this might be right for
Glomerular Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 537
Large-scale testing (Phase 3)Looking for participantsNCT04817618
What this trial is testing

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

Who this might be right for
C3G
Novartis Pharmaceuticals 98
Testing effectiveness (Phase 2)Study completedNCT02480751
What this trial is testing

TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

Who this might be right for
Renal Insufficiency, Chronic
Toray Industries, Inc 113
Not applicableUnknownNCT05294770
What this trial is testing

Dietary Intervention in Obesity-related Glomerulopathy

Who this might be right for
ObesityGlomerulopathy
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 60
Post-approval studies (Phase 4)Looking for participantsNCT05839314
What this trial is testing

Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

Who this might be right for
NephropathyGlomerular DiseasesIdiopathic Membranous Nephropathy
Chinese PLA General Hospital 480
Large-scale testing (Phase 3)Looking for participantsNCT07024563
What this trial is testing

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Who this might be right for
IgANIgAVNImmunoglobulin A Nephropathy+3 more
Alexion Pharmaceuticals, Inc. 36
Next Page